- Home
- EXPI vs IRON Comparison
EXPI vs IRON Comparison
Compare EXPI & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXPI
- IRON
- Stock Information
- Founded
- EXPI 2008
- IRON 2017
- Country
- EXPI United States
- IRON United States
- Employees
- EXPI N/A
- IRON N/A
- Industry
- EXPI Real Estate
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- EXPI Finance
- IRON Health Care
- Exchange
- EXPI Nasdaq
- IRON Nasdaq
- Market Cap
- EXPI 1.4B
- IRON 1.4B
- IPO Year
- EXPI N/A
- IRON N/A
- Fundamental
- Price
- EXPI $7.46
- IRON $44.24
- Analyst Decision
- EXPI Hold
- IRON Strong Buy
- Analyst Count
- EXPI 2
- IRON 10
- Target Price
- EXPI $13.50
- IRON $83.80
- AVG Volume (30 Days)
- EXPI 1.3M
- IRON 397.9K
- Earning Date
- EXPI 05-06-2025
- IRON 05-07-2025
- Dividend Yield
- EXPI 2.69%
- IRON N/A
- EPS Growth
- EXPI N/A
- IRON N/A
- EPS
- EXPI N/A
- IRON N/A
- Revenue
- EXPI $4,579,524,000.00
- IRON N/A
- Revenue This Year
- EXPI $6.88
- IRON N/A
- Revenue Next Year
- EXPI $8.83
- IRON N/A
- P/E Ratio
- EXPI N/A
- IRON N/A
- Revenue Growth
- EXPI 4.83
- IRON N/A
- 52 Week Low
- EXPI $6.91
- IRON $28.25
- 52 Week High
- EXPI $15.39
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- EXPI 28.54
- IRON 45.99
- Support Level
- EXPI $6.90
- IRON $40.36
- Resistance Level
- EXPI $9.50
- IRON $47.21
- Average True Range (ATR)
- EXPI 0.43
- IRON 2.87
- MACD
- EXPI -0.13
- IRON 0.10
- Stochastic Oscillator
- EXPI 21.54
- IRON 37.67
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.